JAMA Neurology Author Interviews

Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease

12.16.2019 - By JAMA NetworkPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Interview with Charbel Moussa, MD, PhD, author of Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial

More episodes from JAMA Neurology Author Interviews